Loading…

Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis : a case report

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal side-effect of antipsychotic drug therapy, especially of dopamine receptor antagonists. As a dose relationship has been postulated, low dose neuroleptization would be expected to help to avoid this side-effect. In contrast, we repo...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacologia 1999-06, Vol.144 (4), p.416-418
Main Authors: GÖNNER, F, BAUMGARTNER, R, SCHÜPBACH, D, MERLO, M. C. G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal side-effect of antipsychotic drug therapy, especially of dopamine receptor antagonists. As a dose relationship has been postulated, low dose neuroleptization would be expected to help to avoid this side-effect. In contrast, we report on a 21-year-old female following low dose fluphenazine treatment with 2.5 mg/day. The patient recovered from NMS after 3 days of dantrolene administration. Eventually, remission from psychotic symptoms was achieved with clozapine. At 8-month follow-up, psychopathology remained stable and there were no more signs of NMS.
ISSN:0033-3158
1432-2072
DOI:10.1007/s002130051026